SCHEMBL9854751

SCHEMBL9854751

Fc1ccc(OCCc2ccccc2OP)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.41
DRD2 P14416 3/20 0.39
DRD3 P35462 3/20 0.39
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39
HRH1 P35367 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
KCNH2 Q12809 1/20 0.39
PPARD Q03181 1/20 0.39
HTR5A P47898 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079979 0.83 L3MBTL1 (0.56) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15079868 0.82 CYP1A2 (0.53) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15079870 0.79 CYP1A2 (0.50) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15079866 0.77 L3MBTL1 (0.53) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15080038 0.77 CYP1A2 (0.49) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL9854722 0.77 MPO (0.51) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15079864 0.76 L3MBTL1 (0.49) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL9854753 0.76 L3MBTL1 (0.45) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL15080035 0.75 MAOB (0.51) L3MBTL1CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL11705264 0.74 HRH1 (0.56) RAB9ANPC1DRD2DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428423-A2 Aryloxy alkyl benzenes, processes for their preparation and pharmaceutical compositions containing them LIPHA S.A. (FR) 1991-05-22 EP disclosed